We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Orthopedic Medical Imaging Pioneer Acquires Exclusive Rights to Scoliosis Prognosis Algorithm

By HospiMedica International staff writers
Posted on 13 Oct 2015
A company that leads in 2-D/3-D orthopedic medical imaging announced that it has acquired the rights to a worldwide license for a 2-D/3-D software that can predict the risk of adolescent patients with mild scoliosis developing severe deformities.

The software algorithm uses various clinical parameters obtained from patient reports to set a predictive score and help determine the risk of young patients with an early and mild scoliosis developing severe scoliosis.

The exclusive rights to the technology were secured by EOS imaging (Paris, France). More...
The software uses 2-D and 3-D parameters from EOS imaging systems. Eight imaging centers equipped with EOS systems centers in the USA, Hong Kong, Singapore, Japan, France, and Canada will evaluate the use of the technology as a predictive tool, as part of a multicenter study.

The software will enable clinicians to predict the risk of severe scoliosis and help them choose between surgery and a brace as the best therapy. EOS imaging is also involved in research to improve the design of such braces using 3-D data of the spine, ribs, and body contours.

CEO of EOS imaging, Marie Meynadier, said, “This promising technology confirms the value of the 3D data naturally associated with EOS images in developing applications and services dedicated to orthopedic care pathways. Acquiring these exclusive rights is an integral part of our global strategy to offer doctors not only cutting-edge imaging technology, but also a full suite of software and services to help them in their therapeutic strategies and execution, to the greatest benefit to patients.”

Related Links:

EOS Imaging



Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Rapid Sepsis Test
SeptiCyte RAPID
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.